Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment.
Dlamini WW, Mirembe BG, Krows ML, Peacock S, Kotze PL, Selepe P, Smit J, Mandona N, Louw C, Nuwagaba-Biribonwoha H, Omollo VO, Zwane Z, Panchia R, Mwelase N, Senne M, Naidoo L, Chihana R, Delany-Moretlwe S, Gill K, MacDonald P, van Heerden A, Bosman S, Peters RPH, du Preez P, Ward A, Celum C, Heffron R, Velloza J; INSIGHT Study Team. Dlamini WW, et al. J Int AIDS Soc. 2025 Feb;28(2):e26422. doi: 10.1002/jia2.26422. J Int AIDS Soc. 2025. PMID: 39956930 Free PMC article.
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.
Gati Mirembe B, Donnell D, Krows M, Zwane Z, Bukusi E, Panchia R, Louw C, Mwelase N, Selepe P, Senne M, Naidoo L, Chihana R, Kasaro M, Nuwagaba-Biribonwoha H, Kotze P, Gill K, MacDonald P, vanHeerden A, Bosman S, Jaggernath M, du Preez P, Ward A, Peters RPH, Delany-Moretlwe S, Peacock S, Johnson R, Caucutt J, Morrison S, Wang G, Gandhi M, Velloza J, Heffron R, Celum C; INSIGHT Study Team. Gati Mirembe B, et al. J Int AIDS Soc. 2024 Dec;27(12):e26389. doi: 10.1002/jia2.26389. J Int AIDS Soc. 2024. PMID: 39653676 Free PMC article.
Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.
Naidoo A, Naidoo K, Letsoalo MP, Wasmann RE, Dorse G, Perumal R, Moosa MS, Osuala EC, Boodhram R, Chimukangara B, Wiesner L, Israelski D, Denti P, Rooney JF, Dooley KE; INSIGHT Study Team. Naidoo A, et al. Lancet HIV. 2025 Dec 1:S2352-3018(25)00200-0. doi: 10.1016/S2352-3018(25)00200-0. Online ahead of print. Lancet HIV. 2025. PMID: 41344350